Atom | Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)

Funding Amounts: Up to $475,000 direct costs per year, maximum 4 years per project (R01 mechanism).

Summary: Supports advanced pre-clinical research to translate nanotechnology-based cancer diagnostics and therapeutics toward clinical application.

Key Information: Clinical trials are not allowed; projects must focus on translational readiness and require strong preliminary data.

Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)